We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$156M
1-Year Est. Return
14.89%
This Fund
S&P 500
This Quarter
Est. Return
+10.63%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$931M
AUM Growth
+$123M
(+15%)
Cap. Flow
+$72.8M
Cap. Flow
% of AUM
7.82%
Top 10 Holdings %
Top 10 Hldgs %
15.02%
Holding
1,150
New
406
Increased
162
Reduced
179
Closed
401
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$21.9M |
| 2 |
Microsoft
MSFT
|
+$16.9M |
| 3 |
Meta Platforms (Facebook)
META
|
+$12.8M |
| 4 |
Starbucks
SBUX
|
+$12.3M |
| 5 |
Procter & Gamble
PG
|
+$11.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$15.7M |
| 2 |
CrowdStrike
CRWD
|
+$9.68M |
| 3 |
Cisco
CSCO
|
+$9.66M |
| 4 |
S&P Global
SPGI
|
+$7.27M |
| 5 |
Stryker
SYK
|
+$6.71M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.77% |
| 2 | Consumer Discretionary | 14.21% |
| 3 | Healthcare | 10.61% |
| 4 | Financials | 9.66% |
| 5 | Consumer Staples | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Fate Therapeutics
FATE
$286M
| $287K | 0.03% |
60,236
+31,900
| +113% | +$176K |
|
552
Clear Secure
YOU
$4.18B
| $287K | 0.03% |
+12,369
| New | +$306K |
|
553
Photronics
PLAB
$1.66B
| $285K | 0.03% |
+11,066
| New | +$205K |
|
|
RNAM
554
DELISTED
Avidity Biosciences
RNAM
| $285K | 0.03% |
+25,700
| New | +$322K |
|
555
Aaon
AAON
$6.27B
| $284K | 0.03% |
4,500
-21
| -0.5% | -$1.33K |
|
556
Acadia Pharmaceuticals
ACAD
$4.7B
| $283K | 0.03% |
11,837
+337
| +3% | +$7.49K |
|
557
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.07B
| $283K | 0.03% |
+2,200
| New | +$276K |
|
558
Middleby
MIDD
$5.12B
| $281K | 0.03% |
1,899
-2,100
| -53% | -$296K |
|
|
FSR
559
DELISTED
Fisker Inc.
FSR
| $275K | 0.03% |
48,800
+5,900
| +14% | +$34K |
|
560
Fabrinet
FN
$14.1B
| $275K | 0.03% |
+2,118
| New | +$226K |
|
561
Terex
TEX
$6.83B
| $274K | 0.03% |
4,579
-628
| -12% | -$31.1K |
|
562
Charles River Laboratories
CRL
$13.3B
| $273K | 0.03% |
+1,300
| New | +$259K |
|
563
Simpson Manufacturing
SSD
$7.1B
| $273K | 0.03% |
+1,970
| New | +$242K |
|
564
Coursera
COUR
$1.37B
| $272K | 0.03% |
+20,900
| New | +$250K |
|
565
Napco Security Technologies
NSSC
$1.29B
| $272K | 0.03% |
+7,853
| New | +$274K |
|
566
Newell Brands
NWL
$2.45B
| $271K | 0.03% |
+31,179
| New | +$310K |
|
567
Viking Therapeutics
VKTX
$3.57B
| $270K | 0.03% |
+16,664
| New | +$349K |
|
568
Tencent Music
TME
$12.8B
| $266K | 0.03% |
+36,105
| New | +$273K |
|
569
Universal Display
OLED
$3.55B
| $266K | 0.03% |
1,846
-1,900
| -51% | -$272K |
|
570
Roivant Sciences
ROIV
$29B
| $266K | 0.03% |
+26,376
| New | +$236K |
|
|
GRMN
571
Garmin
GRMN
$53.6B
| $265K | 0.03% |
+2,540
| New | +$260K |
|
|
ELME
572
Elme Communities
ELME
$146M
| $263K | 0.03% |
16,005
-500
| -3% | -$8.26K |
|
573
RB Global
RBA
$16B
| $263K | 0.03% |
4,381
-2,900
| -40% | -$164K |
|
574
indie Semiconductor
INDI
$705M
| $262K | 0.03% |
27,826
+17,410
| +167% | +$157K |
|
575
Autohome
ATHM
$2.46B
| $261K | 0.03% |
8,955
-10,100
| -53% | -$302K |
|
Similar funds
MCM
MFG
AFW
ADBIC
HSM
FWM
PIA
CCP
Bayesian Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Bayesian Capital Management held 1,150 positions worth $931M, up 15% from $808M the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Bayesian Capital Management deployed $72.8M of net new capital in Q2 2023, opening 406 new positions and adding to 162 existing holdings. Its largest new stake was NVIDIA: 660,000 shares worth $27.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was S&P Global, an estimated $7.27M trimmed.
- Bayesian Capital Management's largest Q2 2023 buy was NVIDIA: 660,000 shares worth $27.9M.
- Bayesian Capital Management added most to Coca-Cola in Q2 2023, an estimated $10.9M increase.
- Bayesian Capital Management's biggest Q2 2023 reduction was S&P Global, cutting an estimated $7.27M.
- Bayesian Capital Management fully exited Tesla in Q2 2023, selling an estimated $15.7M.
- Bayesian Capital Management's ten largest holdings make up 15% of its $931M portfolio in Q2 2023.
- Bayesian Capital Management opened 406 new positions and closed 401 in Q2 2023.
- Bayesian Capital Management's portfolio value rose 15% quarter-over-quarter to $931M.
Based on Bayesian Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.